CAAS Capital Management’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-63,383	Closed	-$2.4M	–	614
2021 Q2	$2.4M	Buy	+63,383	New	+$2.4M	0.04%	140